152 related articles for article (PubMed ID: 25525550)
1. A challenging twist in pulmonary renal syndrome.
Namas R; Rubin B; Adwar W; Meysami A
Case Rep Rheumatol; 2014; 2014():516362. PubMed ID: 25525550
[TBL] [Abstract][Full Text] [Related]
2. Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report.
Keasberry J; Frazier J; Isbel NM; Van Eps CL; Oliver K; Mudge DW
J Med Case Rep; 2013 Jan; 7():20. PubMed ID: 23316942
[TBL] [Abstract][Full Text] [Related]
3. Something Out of Nothing: A Rare Case of Pulmonary Renal Syndrome With Pauci-Immune Glomerulonephritis and Diffuse Alveolar Hemorrhage With Negative Serologies.
Wang LJ; Collazo-Maldonado R
Cureus; 2021 Oct; 13(10):e18614. PubMed ID: 34765369
[TBL] [Abstract][Full Text] [Related]
4. Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.
Dobre M; Wish J; Negrea L
Ren Fail; 2009; 31(8):745-8. PubMed ID: 19814644
[TBL] [Abstract][Full Text] [Related]
5. Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report.
Al-Abdouh A; Siyal AM; Seid H; Bekele A; Garcia P
J Med Case Rep; 2020 Apr; 14(1):47. PubMed ID: 32290867
[TBL] [Abstract][Full Text] [Related]
6. Hydralazine induces myeloperoxidase and proteinase 3 anti-neutrophil cytoplasmic antibody vasculitis and leads to pulmonary renal syndrome.
Agarwal G; Sultan G; Werner SL; Hura C
Case Rep Nephrol; 2014; 2014():868590. PubMed ID: 25210633
[TBL] [Abstract][Full Text] [Related]
7. A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage.
Xue A; Bernard A; Moreno V; Phillips L; Raff E
Cureus; 2023 Oct; 15(10):e47591. PubMed ID: 38022102
[TBL] [Abstract][Full Text] [Related]
8. Anti-neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis Secondary to Hydralazine: A Case Report.
Abdullah A; Anwar MS; Ijaz M; Karim MS; Rosen R; Bokhari SRA
Cureus; 2022 Dec; 14(12):e32603. PubMed ID: 36654641
[TBL] [Abstract][Full Text] [Related]
9. Fulminant Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis After 10 Years of Hydralazine Use.
Russe-Russe JR; Pellegrini JR; Alvarez-Betancourt A; Munshi RF; Anand P
Cureus; 2021 Oct; 13(10):e18974. PubMed ID: 34820229
[TBL] [Abstract][Full Text] [Related]
10. Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted Presentation.
Tu W; Fayman B; Ward SC; Mamoon Y; Bandagi SS
Am J Case Rep; 2021 May; 22():e931263. PubMed ID: 33993184
[TBL] [Abstract][Full Text] [Related]
11. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis.
Kumar B; Strouse J; Swee M; Lenert P; Suneja M
Semin Arthritis Rheum; 2018 Oct; 48(2):283-287. PubMed ID: 29519741
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
[TBL] [Abstract][Full Text] [Related]
13. Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis.
Zuckerman R; Patel M; Costanzo EJ; Dounis H; Haj RA; Seyedali S; Asif A
J Bras Nefrol; 2018; 40(2):193-197. PubMed ID: 29738027
[TBL] [Abstract][Full Text] [Related]
14. New-onset microscopic polyangiitis temporally associated with severe COVID-19 infection: A case report.
Meade-Aguilar JA; Varela-Martinez YN; Ramirez-Eguía SP; Sanchez-Hurtado E; Mondragón-Labelle TO; Bautista-Aguilar GA; Deloya-Tomas E; Phinder-Puente ME; Pérez Nieto OR
SAGE Open Med Case Rep; 2023; 11():2050313X231185617. PubMed ID: 37434895
[TBL] [Abstract][Full Text] [Related]
15. Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report.
Shida H; Hashimoto N; Kusunoki Y; Hattanda F; Ogawa Y; Hayashi T; Nakazawa D; Masuda S; Tomaru U; Ishizu A
BMC Nephrol; 2018 Jun; 19(1):145. PubMed ID: 29929470
[TBL] [Abstract][Full Text] [Related]
16. Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.
Marina VP; Malhotra D; Kaw D
Int Urol Nephrol; 2012 Dec; 44(6):1907-9. PubMed ID: 21590349
[TBL] [Abstract][Full Text] [Related]
17. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
[TBL] [Abstract][Full Text] [Related]
18. AP-VAS 2012 case report: anti-glomerular basement membrane disease with high titer of myeloperoxidase anti-neutrophil cytoplasmic antibody-an autopsy case report.
Otani M; Shoji H; Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Nakajima Y; Katsuyama E
CEN Case Rep; 2013 Nov; 2(2):154-157. PubMed ID: 28509301
[TBL] [Abstract][Full Text] [Related]
19. Not Lupus Nephritis but a Rare Case of Drug-Induced Pauci-Immune Glomerulonephritis.
Hang S; Dixit P; Fatima S; Alam D; Webster C
Cureus; 2022 Jan; 14(1):e21549. PubMed ID: 35223320
[TBL] [Abstract][Full Text] [Related]
20. Dual anti-neutrophil cytoplasmic antibody-related pauci-immune crescentic glomerulonephritis in a patient with Sjögren's syndrome.
Lee IH; Kim SK; Kim MK
Rheumatol Int; 2016 Sep; 36(9):1327-34. PubMed ID: 27384449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]